Ignite Creation Date:
2024-05-06 @ 3:49 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02386111
Status:
TERMINATED
Last Update Posted:
2018-07-26
First Post:
2015-03-06
Brief Title:
A Study of Varlilumab Anti-CD27 and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Sponsor:
Celldex Therapeutics
Organization:
Celldex Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2017-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-06
First Submit QC Date:
March 10 2015
Study First Post Date:
2015-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-24
Last Update Post Date:
2018-07-26
Last Update Post Date Type:
ACTUAL